| Document Date: 2013-11-17 21:14:59
Open Document File Size: 292,47 KBShare Result on Facebook
City Copenhagen / / Company GE / / Country Canada / / IndustryTerm normal food intake / atherogenic carrier proteins / food intake / prevention of cardiovascular disease / / MedicalCondition metabolic syndrome / J Diabetes / vascular disease / diabetes mellitus / JE / CHD / pancreatitis / fainting / coronary heart disease / atherogenesis / fatal and nonfatal coronary heart disease / hypertriglyceridemia / dyslipidemia / cardiovascular disease / diabetes / / MedicalTreatment hemodilution / drug therapy / / Organization Canadian Cardiovascular Society / Association of LDL / Canadian Diabetes Association / United Nations / American Medical Association / / Person Ridker / / Position Prime Minister / / PublishedMedium the Archives of Internal Medicine / the Journal of the American Medical Association / / RadioStation Spijkerman AM / / Technology CVD / / URL www.oaml.com / /
SocialTag |
November, 2013 Community Laboratories Introduce the Option of Using Non-Fasting Specimens for the Measurement of Lipid Levels (C024) Traditionally, screening for type 2 diabetes required a fasting specimen for glucose a